These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32877464)

  • 1. Evaluation of molecular inversion probe versus TruSeq® custom methods for targeted next-generation sequencing.
    Almomani R; Marchi M; Sopacua M; Lindsey P; Salvi E; Koning B; Santoro S; Magri S; Smeets HJM; Martinelli Boneschi F; Malik RR; Ziegler D; Hoeijmakers JGJ; Bönhof G; Dib-Hajj S; Waxman SG; Merkies ISJ; Lauria G; Faber CG; Gerrits MM;
    PLoS One; 2020; 15(9):e0238467. PubMed ID: 32877464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants.
    Shin S; Hwang IS; Lee ST; Choi JR
    Breast Cancer Res Treat; 2016 Aug; 158(3):433-40. PubMed ID: 27383479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Profiling of Sodium Channels in Diabetic Painful and Painless and Idiopathic Painful and Painless Neuropathies.
    Almomani R; Sopacua M; Marchi M; Ślęczkowska M; Lindsey P; de Greef BTA; Hoeijmakers JGJ; Salvi E; Merkies ISJ; Ferdousi M; Malik RA; Ziegler D; Derks KWJ; Boenhof G; Martinelli-Boneschi F; Cazzato D; Lombardi R; Dib-Hajj S; Waxman SG; Smeets HJM; Gerrits MM; Faber CG; Lauria G; On Behalf Of The Propane Study Group
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
    Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations.
    Zanella I; Merola F; Biasiotto G; Archetti S; Spinelli E; Di Lorenzo D
    Exp Mol Pathol; 2017 Apr; 102(2):314-320. PubMed ID: 28263838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A low-cost exon capture method suitable for large-scale screening of genetic deafness by the massively-parallel sequencing approach.
    Tang W; Qian D; Ahmad S; Mattox D; Todd NW; Han H; Huang S; Li Y; Wang Y; Li H; Lin X
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):536-42. PubMed ID: 22480152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
    Yao R; Yu T; Qing Y; Wang J; Shen Y
    Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic testing for monogenic diabetes using targeted next-generation sequencing in patients with maturity-onset diabetes of the young.
    Szopa M; Ludwig-Gałęzowska A; Radkowski P; Skupień J; Zapała B; Płatek T; Klupa T; Kieć-Wilk B; Borowiec M; Młynarski W; Wołkow P; Małecki MT
    Pol Arch Med Wewn; 2015; 125(11):845-51. PubMed ID: 26552609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next Generation Sequencing Based Multiplex Long-Range PCR for Routine Genotyping of Autoinflammatory Disorders.
    Guzel F; Romano M; Keles E; Piskin D; Ozen S; Poyrazoglu H; Kasapcopur O; Demirkaya E
    Front Immunol; 2021; 12():666273. PubMed ID: 34177904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.
    Mu W; Lu HM; Chen J; Li S; Elliott AM
    J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral Ion Channel Genes Screening in Painful Small Fiber Neuropathy.
    Ślęczkowska M; Almomani R; Marchi M; Salvi E; de Greef BTA; Sopacua M; Hoeijmakers JGJ; Lindsey P; Waxman SG; Lauria G; Faber CG; Smeets HJM; Gerrits MM
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of BRCA1/2 large genomic rearrangement including BRCA1 promoter-region deletions using next-generation sequencing.
    Han E; Yoo J; Chae H; Lee S; Kim DH; Kim KJ; Kim Y; Kim M
    Clin Chim Acta; 2020 Jun; 505():49-54. PubMed ID: 32092317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial and nuclear disease panel (Mito-aND-Panel): Combined sequencing of mitochondrial and nuclear DNA by a cost-effective and sensitive NGS-based method.
    Abicht A; Scharf F; Kleinle S; Schön U; Holinski-Feder E; Horvath R; Benet-Pagès A; Diebold I
    Mol Genet Genomic Med; 2018 Nov; 6(6):1188-1198. PubMed ID: 30406974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted next-generation sequencing for the detection of ciprofloxacin resistance markers using molecular inversion probes.
    Stefan CP; Koehler JW; Minogue TD
    Sci Rep; 2016 May; 6():25904. PubMed ID: 27174456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the pharmacogenome using molecular inversion probes for targeted next-generation sequencing.
    Suzuki O; Dong OM; Howard RM; Wiltshire T
    Pharmacogenomics; 2019 Sep; 20(14):1005-1020. PubMed ID: 31559919
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical utility of custom-designed NGS panel testing in pediatric tumors.
    Surrey LF; MacFarland SP; Chang F; Cao K; Rathi KS; Akgumus GT; Gallo D; Lin F; Gleason A; Raman P; Aplenc R; Bagatell R; Minturn J; Mosse Y; Santi M; Tasian SK; Waanders AJ; Sarmady M; Maris JM; Hunger SP; Li MM
    Genome Med; 2019 May; 11(1):32. PubMed ID: 31133068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: molecular spectrum delineation.
    Bacquet J; Stojkovic T; Boyer A; Martini N; Audic F; Chabrol B; Salort-Campana E; Delmont E; Desvignes JP; Verschueren A; Attarian S; Chaussenot A; Delague V; Levy N; Bonello-Palot N
    BMJ Open; 2018 Oct; 8(10):e021632. PubMed ID: 30373780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Next-Generation Sequencing in Patients with Non-syndromic Congenital Heart Disease.
    Pulignani S; Vecoli C; Borghini A; Foffa I; Ait-Alì L; Andreassi MG
    Pediatr Cardiol; 2018 Apr; 39(4):682-689. PubMed ID: 29332214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants.
    Beck TF; Mullikin JC; ; Biesecker LG
    Clin Chem; 2016 Apr; 62(4):647-54. PubMed ID: 26847218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.